Podcast episode 24 (in German)
Epitalon: Telomere lengthening as anti-aging fact-checked
July 4, 2026
A peptide made of just 4 building blocks, derived from the pineal gland, is supposed to switch telomerase back on and thereby turn back the aging clock of cells. Epitalon is one of the most fascinating longevity peptides, and almost everything known about it comes from a single research group.
What it is about
Epitalon is the synthetic, defined version of epithalamin, an extract of the pineal gland. It comes from the Institute of Bioregulation and Gerontology in St. Petersburg, from the school of Khavinson, whose idea of short bioregulator peptides as control signals for individual tissues the episode explains. At the center are the telomeres, the protective caps of the chromosomes that get shorter with every cell division, and the enzyme telomerase, which can lengthen them. Epitalon is supposed to switch on the gene TERT, which builds telomerase. In addition there is a noticeable side: because it derives from the pineal gland, it apparently intervenes in the melatonin and sleep rhythm. The conclusion is an elegant mechanism with a strong laboratory signal whose independent confirmation is still pending.
Key points
- Epitalon is a synthetic peptide made of just 4 amino acids and derives from the pineal gland, the same gland that also produces the sleep hormone melatonin.
- In a 2003 study, Khavinson’s group treated human cells with epitalon; telomerase activity rose measurably, and the cells were able to divide more often.
- A report on a 12-year observation of older heart patients treated with pineal peptides cites fewer deaths in the treated group.
- Anecdotal report: many users first notice better sleep, already within the first 1 to 2 weeks, often together with more energy, better mood and less feeling of stress.
- In the data and user reports so far, the safety profile is considered mild, with few reports of real problems and no conspicuous cancer signal.
- Telomeres are only one construction site of aging among many; alongside them the episode names mitochondria, the growth switch mTOR, chronic inflammation and old “zombie cells” that do not step down.
Where the data stop
Almost all the research, from cell culture to long-term data, comes from Khavinson’s group in Russia. Independent, large studies that replicate the results are largely missing, and part of the human data consists of case reports and smaller open-label studies rather than strictly blinded comparisons. Better sleep is a real, pleasant effect, but it is no evidence that the cellular clock is being turned back in the background.
There is also a fundamental question: the same telomerase that keeps cells young makes cancer cells immortal. Long-term safety in healthy long-term users has not been seriously studied, and longer telomeres do not automatically mean a longer life in humans. Epitalon is not approved as a medicine in Germany, as of July 2026; purity and amount in the vial are not assured without analysis.
Listen (in German)
Listen on Spotify Listen on Apple Podcasts Listen on Amazon Music
Published on July 4, 2026.
The topic in the database
- A pineal tetrapeptide from the Khavinson school. Telomerase activation in human cells has been independently confirmed since 2025 – human stu…Epitalon (Epithalon)
All episodes in the app (German)
Information only, not medical advice and not a usage or dosage recommendation. Prescription-only and unapproved substances belong in the hands of a physician. Last updated: 2026-10-09.